10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001410578-23-001588`
Period End Date	20230630
Filing Date	20230808
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	cldx-20230630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 69 Cash Flow Statement 56

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.43M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$224.47M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$275.52M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$118.00K	USD	Point-in-time
Accounts and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$347.00K	USD	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.01M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Prepaid and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.39M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.25M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$317.69M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$264.82M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.20M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.75M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.25M	shares	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.00M	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$3.26M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$27.19M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$104.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$107.00K	USD	Point-in-time
Total assets	`Assets`	$299.31M	USD	Point-in-time
Total assets	`Assets`	$352.74M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$881.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.34M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.84M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.45M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.53M	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$978.00K	USD	Point-in-time
Current portion of other long-term liabilities	`OtherLiabilitiesCurrent`	$990.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.59M	USD	Point-in-time
Long-term portion of operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.73M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.33M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$21.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.53M	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $.01 par value; 3,000,000 shares authorized; no shares issued and outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,253,813 and 47,200,695 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $.001 par value; 297,000,000 shares authorized; 47,253,813 and 47,200,695 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.59B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.58B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.26M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.26B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.32B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$398.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$326.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$277.54M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$302.74M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$365.09M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$419.48M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$352.74M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$299.31M	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$163.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$268.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.23M	USD	2 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$337.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$20.73M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$37.79M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$53.05M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$26.25M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.86M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$14.07M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.15M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.22M	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	2 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.86M	USD	2 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.33M	USD	1 Quarter
Litigation settlement related loss	`GainLossRelatedToLitigationSettlement`	$-15.00M	USD	1 Quarter
Litigation settlement related loss	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Litigation settlement related loss	`GainLossRelatedToLitigationSettlement`	$-15.00M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$66.91M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$33.47M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$36.56M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$59.99M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-65.68M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-36.40M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-33.20M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-59.65M	USD	2 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$5.81M	USD	2 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$2.70M	USD	1 Quarter
Investment and other income, net	`InterestAndOtherIncome`	$599.00K	USD	2 Qtrs
Investment and other income, net	`InterestAndOtherIncome`	$392.00K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.86M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.05M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-0.65	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-1.27	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-0.77	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareBasic`	$-1.26	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-0.77	USD	1 Quarter
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-1.26	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-1.27	USD	2 Qtrs
Basic and diluted net loss per common share	`EarningsPerShareDiluted`	$-0.65	USD	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46,759.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	47,253.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	47,233.00	shares	2 Qtrs
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	46,749.00	shares	2 Qtrs
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	47,253.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	47,233.00	shares	2 Qtrs
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46,759.00	shares	1 Quarter
Shares used in calculating basic and diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	46,749.00	shares	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.86M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.05M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$863.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-51.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.78M	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$812.00K	USD	2 Qtrs
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-529.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.31M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-36.53M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-59.05M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-30.55M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-61.37M	USD	2 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.86M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-29.36M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-30.50M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.05M	USD	2 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.00M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.05M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.55M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.48M	USD	2 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.42M	USD	2 Qtrs
Amortization and premium of marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.31M	USD	2 Qtrs
Loss (gain) on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Loss (gain) on sale or disposal of assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-57.00K	USD	2 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	1 Quarter
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	2 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.86M	USD	2 Qtrs
Gain on fair value remeasurement of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$6.33M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$6.61M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.56M	USD	2 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-75.00K	USD	2 Qtrs
Accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-229.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$3.00K	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.48M	USD	2 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$61.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.97M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-862.00K	USD	2 Qtrs
Litigation settlement payable	`GainLossRelatedToLitigationSettlement`	$-15.00M	USD	1 Quarter
Litigation settlement payable	`GainLossRelatedToLitigationSettlement`	-	USD	2 Qtrs
Litigation settlement payable	`GainLossRelatedToLitigationSettlement`	$-15.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.89M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.72M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.77M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-46.78M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$210.15M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$106.76M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$155.42M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$69.85M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.25M	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$995.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$53.73M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$35.66M	USD	2 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$827.00K	USD	2 Qtrs
Proceeds from issuance of stock from employee benefit plans	`ProceedsFromStockPlans`	$375.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$827.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$375.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.21M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-10.74M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.40M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.43M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$46.00K	USD	2 Qtrs
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$54.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.